Subsequently, we showed that ADH-6 effectively targeted and dissociated cytosolic amyloid-like aggregates of a range of aggregation-prone p53 mutants in a variety of human cancer cells, which restored p53’s transcriptional activity, leading to cell cycle arrest and apoptosis (Figure 2) [229]. The gene discussed is TP53; the disease is cancer.